Abstract | BACKGROUND: A graft-versus- lymphoma effect against diffuse large B-cell lymphoma (DLBCL) is inferred by sustained relapse-free survival after allogeneic stem-cell transplantation; however, there are limited data on a direct graft-versus- lymphoma effect against DLBCL following immunotherapeutic intervention by either withdrawal of immunosuppression or donor lymphocyte infusion (DLI). MATERIALS AND METHODS: An analysis was carried out to determine whether a direct graft-versus- lymphoma effect exists against DLBCL. The analysis was restricted to patients with DLBCL, who were either not in complete remission at day +100 after allogeneic stem-cell transplantation or subsequently relapsed beyond this time point. RESULTS: Fifteen patients were identified as either not in complete remission (n = 13) at their day +100 evaluation or subsequently relapsed (n = 2) and were assessed for subsequent responses after withdrawal of immunosuppression or DLI. Eleven patients were treated with either withdrawal of immunosuppression (n = 10) or a DLI (n = 1) alone; four patients received chemotherapy with DLI to reduce tumor bulk. Nine (60%) patients subsequently responded (complete = 8, partial = 1). Six responses occurred after withdrawal of immunosuppression alone. Six patients are alive (range 42-83+ months) in complete remission without further treatment. CONCLUSION: The demonstration of sustained complete remission following immunotherapeutic intervention provides direct evidence of a graft-versus- lymphoma effect against DLBCL.
|
Authors | M R Bishop, R M Dean, S M Steinberg, J Odom, S Z Pavletic, C Chow, S Pittaluga, C Sportes, N M Hardy, J Gea-Banacloche, A Kolstad, R E Gress, D H Fowler |
Journal | Annals of oncology : official journal of the European Society for Medical Oncology
(Ann Oncol)
Vol. 19
Issue 11
Pg. 1935-40
(Nov 2008)
ISSN: 1569-8041 [Electronic] England |
PMID | 18684698
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Topics |
- Adult
- Aged
- Female
- Graft vs Tumor Effect
(immunology)
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphoma, Large B-Cell, Diffuse
(immunology, therapy)
- Male
- Middle Aged
|